Search Results
Apr 01, 2026, 06:00 ET Corti Ships Symphony for Medical Coding with more than 25% Accuracy Edge Over OpenAI and Anthropic
practice management systems, and life sciences organizations worldwide. Corti serves over 100 million patients annually across health systems including the NHS. The company is headquartered in Copenhagen with offices in New York and London. For more information, visit corti.ai.Media Contact:
More news about: Corti
Apr 01, 2026, 06:00 ET Corti Ships Symphony for Medical Coding with more than 25% Accuracy Edge Over OpenAI and Anthropic
practice management systems, and life sciences organizations worldwide. Corti serves over 100 million patients annually across health systems including the NHS. The company is headquartered in Copenhagen with offices in New York and London. For more information, visit corti.ai.Media Contact:
More news about: Corti
Mar 31, 2026, 10:14 ET i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
operational milestone with the first participant successfully randomized and treated in the United Kingdom at London North West University Healthcare NHS Trust under the leadership of Ms. Christiana Dinah, Director of Research and Innovation. "This population of AMD patients with vision loss has very limited
More news about: i-LUMEN SCIENTIFIC, Inc.
Mar 31, 2026, 10:14 ET i-Lumen Scientific Receives FDA Approval of IDE to Initiate U.S. Enrollment in i-SIGHT2 Clinical Study for dry AMD
operational milestone with the first participant successfully randomized and treated in the United Kingdom at London North West University Healthcare NHS Trust under the leadership of Ms. Christiana Dinah, Director of Research and Innovation. "This population of AMD patients with vision loss has very limited
More news about: i-LUMEN SCIENTIFIC, Inc.
Mar 30, 2026, 18:30 ET A Universities Space Research Association (USRA)-Led Study Links Great Salt Lake Desiccation to Worsening Air Quality and Rising Mental Health Burden
Oxford Health NHS Foundation Trust. The NIHR OH BRC is run-in partnership with the University of Oxford and involves 13 additional partner university and NHS Trusts across England. Support for infrastructure is provided by the
More news about: Universities Space Research Association
Mar 26, 2026, 09:13 ET Audos.com ACQUIRES NO CAP AND ANNOUNCES FIRST COHORT OF SOLOPRENEURS BUILDING MILLION-DOLLAR AI-NATIVE BUSINESSES
helping parents coordinate medications, appointments, and routines for children with complex medical needs. Cartee is serving families navigating both the NHS and US healthcare systems.Dr. Jonathan Avery, VP of Addiction Psychiatry at Cornell Weil, based in New York City, who built
More news about: Audos
Mar 25, 2026, 11:57 ET Ideal Strategic Partners® Showcases Five Retail-Ready Hardware Brands at National Hardware Show 2026
Ideal Strategic Partners® NHS BrandsFor media inquiries, wholesale opportunities, or partnership information, please contact
More news about: Ideal Strategic Partners
Mar 25, 2026, 11:47 ET CHIME UK Welcomes Introduction of Professional Standards for NHS Digital Health Workforce
forthcoming professional requirements for NHS digital health professionals, marking an important milestone in strengthening the digital workforce across the United Kingdom. While formal timelines and detailed guidance are expected to be confirmed by the NHS soon, this development signals clear progress
More news about: College of Healthcare Information Management Executives (CHIME)
Mar 25, 2026, 09:00 ET GRAL DROPS ~50% -- REPORTED NUMBERS VS. ACTUAL RESULTS; LEVI & KORSINSKY, LLP INVESTIGATES
Grail, Inc. (NASDAQ: GRAL) investors lost approximately half the value of their holdings when the stock plunged roughly 50% following disclosure that the NHS Galleri trial missed its primary endpoint. If you lost money on GRAL,
More news about: Levi & Korsinsky, LLP
Mar 25, 2026, 09:00 ET Heidi Receives Frost & Sullivan's 2026 North American Technology Innovation Leadership Recognition for Excellence in Artificial Intelligence Medical Scribe Innovation
Blackbird, Headline, Phoenix Court's growth fund - Latitude, Possible Ventures, and Archangel. Heidi adheres to international standards including the NHS, HIPAA, GDPR, and Australian Privacy Principles, and has obtained enterprise-grade security certifications such as SOC2 and ISO27001.
More news about: Frost & Sullivan
Mar 25, 2026, 09:00 ET Heidi Receives Frost & Sullivan's 2026 North American Technology Innovation Leadership Recognition for Excellence in Artificial Intelligence Medical Scribe Innovation
Blackbird, Headline, Phoenix Court's growth fund - Latitude, Possible Ventures, and Archangel. Heidi adheres to international standards including the NHS, HIPAA, GDPR, and Australian Privacy Principles, and has obtained enterprise-grade security certifications such as SOC2 and ISO27001.
More news about: Frost & Sullivan
Mar 24, 2026, 09:30 ET First Parkinson's Patients Treated in Landmark Phase 2 Trial of Dapansutrile - Expanding a Leading Oral NLRP3 Inhibitor into Neurological Diseases
DAPA-PD trial is a single-center randomized, double-blind, placebo-controlled study being conducted at Cambridge University Hospitals NHS Foundation Trust/University of Cambridge under principal investigator, Dr. Caroline Williams-Gray, BMBCh, FRCP, PhD, and funded by Cure Parkinson's and
More news about: Olatec Therapeutics, Inc.
Mar 24, 2026, 07:00 ET Karyopharm's Phase 3 SENTRY Trial in Myelofibrosis Met First Co-Primary Endpoint, Demonstrating Statistically Significant Improvement in Spleen Volume Reduction
Claire Harrison, Professor of Myeloproliferative Neoplasms and Deputy Chief Medical Officer of Research, Data, and Analytics at Guy's and St. Thomas' NHS Foundation Trust in the United Kingdom."Selinexor's differentiated mechanism provides a complementary approach to JAK inhibition and highlights
More news about: Karyopharm Therapeutics Inc.
Mar 24, 2026, 06:00 ET BetterMe launches diabetes-friendly workouts to support people living with the condition, in collaboration with Diabetes UK
driven many of the biggest breakthroughs in diabetes care - improving millions of lives. The charity also drives change by influencing policy and the NHS, as well as raising awareness and combatting misconceptions about diabetes.For more information about Diabetes UK, visit
More news about: BetterMe
Mar 23, 2026, 08:30 ET Reduce Discovery Risk Using Comorbidity Data, Omics and Knowledge Graphs, Upcoming Webinar Hosted by Xtalks
molecular interaction network to clarify associated biological functions and support hypothesis generation.This webinar will be based on a 2022 NHS population study on multimorbidity and comorbidity1, which demonstrates how large-scale datasets can be used to propose mechanistic hypotheses that help
More news about: Xtalks
Mar 18, 2026, 12:00 ET SimpliContract Introduces mNemoAI™: The AI Engine Powering Enterprise Contract Intelligence
compliance, reduced revenue leakage, improved audit readiness, and faster decision-makingGlobal organizations including Reckitt, Cyient, and NHS BHRUT are using SimpliContract to transform how contracts are understood, governed, and operationalized across the enterprise."SimpliContract
More news about: SimpliContract
Mar 18, 2026, 10:27 ET NHS Discount Offers Highlights Ongoing Nandos Discount for UK Blue Light Workers
may vary by restaurant. To redeem the discount, NHS staff are usually required to present a valid NHS ID card or verify their eligibility through a recognised platform.NHS Discount Offers, which aggregates and verifies deals specifically for NHS employees, plays a key role in ensuring that healthcare
More news about: NHS Discount Offers
Mar 18, 2026, 09:00 ET LEVI & KORSINSKY, LLP: GRAIL (GRAL) GUIDED TO 2030 CASH RUNWAY WHILE KEY TRIAL RISK WENT UNADDRESSED
would be reached.Those milestones centered on the 140,000-participant NHS Galleri study and a modular PMA submission to the FDA. The cash-runway projection and burn-rate guidance did not reference any scenario in which the NHS trial missed its primary endpoint. When that outcome was disclosed in February
More news about: Levi & Korsinsky, LLP
Mar 16, 2026, 10:01 ET Neuromyelitis Optica Spectrum Disorder Market Poised for Robust Expansion Through 2036 | DelveInsight
2025, NHS England introduced a national commissioning policy that recommends and funds the use of ACTEMRA (tocilizumab) for NMOSD patients who are unable to tolerate or have not responded to earlier treatments. ACTEMRA is delivered through specialised neurology centres under NHS England.
More news about: DelveInsight Business Research, LLP
Mar 16, 2026, 09:00 ET /R E P E A T --Claigan Webinar - Beyond the Greenwash: A Technical Masterclass on LCA, EPD & PCR for Electronics/
year-over-year improvements. Nobody wants to be shut out of a purchasing tender while their competitors gain the edge. And by 2028, all products sold to the NHS in the UK require specific carbon foot printing via the LCA process.Moving past the high-level overviews that dominate the industry, this webinar
More news about: Claigan Environmental Inc.
Mar 12, 2026, 16:45 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES RIGHTS OFFERING AND SUMMARY OF TERMS
NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced approval of the terms of the issuance of transferable rights ("Rights") to the holders of the Fund's common stock (par value
More news about: Neuberger Berman
Mar 12, 2026, 16:30 ET NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES EARLY DECLARATION OF REGULAR MONTHLY DISTRIBUTION
NEW YORK, March 12, 2026 /PRNewswire/ -- Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced an early declaration of the Fund's regular monthly distribution payable in April. The $0.0905 per share of common stock
More news about: Neuberger Berman
Mar 11, 2026, 09:00 ET Kneu Health Graduates from Texas Medical Center Innovation Accelerator as U.S. Deployments Expand
intervention and personalized care. Backed by Oxford Science Enterprises, Cedars-Sinai, and a global syndicate of investors, Kneu operates across eight NHS Trusts and flagship U.S. health systems. Learn more at
More news about: Kneu Health
Mar 09, 2026, 09:00 ET Kneu Health Validates Precision Neurology Platform in Cedars-Sinai Clinical Deployment
Parkinson's tremor measurement and is expanding adoption across U.S. academic and specialty health systems, with additional deployment across multiple NHS Trusts in the United Kingdom. The Cedars-Sinai clinical integration builds on more than a decade of Oxford's neurological research, and reflects the
More news about: Kneu Health
Mar 05, 2026, 07:00 ET Hemab Therapeutics Receives FDA Breakthrough Therapy Designation for Sutacimig in Glanzmann Thrombasthenia
unmet need for people living with Glanzmann thrombasthenia is clear," said Suthesh Sivapalaratnam, MD, PhD, Consultant Haematologist at Barts Health NHS Trust and Associate Professor at Queen Mary University of London. "This Breakthrough Therapy Designation is a critical step towards a potentially better
More news about: Hemab Therapeutics